Use of dried blood spots (DBS) or dried serum/plasma spots (DSS/DPS) to detect recent HIV-1 seroconversion by the BED-CEIA Bharat Parekh, PhD Centers for.

Slides:



Advertisements
Similar presentations
Preparation, characterization and establishment of a WHO International Biological Reference Preparation Dr Sjoerd Rijpkema Division of Bacteriology NIBSC.
Advertisements

Module 14: Blood Collection and Handling Dried Blood Spot
DBS – Process & Review GHANSHYAM. 3Rs No need to explain…………… GOAL IS ANIMAL SAVING R1 REPLACEMENT R2 REFINEMENT R3 REDUCTION.
Field Study of the Utility of Dried Blood Spots (DBS) for HIV-1 Drug Resistance (HIVDR) Genotyping Storage for 2 Weeks and Shipping at Ambient Temperature.
Development of an oral fluid assay capable of differentiating recent from established HIV infection Niel Constantine 1, Ligia Peralta 1, Anne Sill 2, Kristen.
HIV-1/HIV-2 PLUS O To detect HIV Antibody Groups M & O Genetic Systems™ HIV-1/HIV-2 PLUS O EIA   HIV Subtypes and Variants   Description of HIV-1/HIV-2.
Hemoglobin A 2 Practical Hematology Lab - LAB 6 -.
Performance of Bio-Rad Genetic Systems HIV-1/HIV-2 Plus O EIA Followed by Multispot or OraQuick Advance in a Dual Immunoassay HIV Testing Strategy Laura.
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
Validating 16 Member Pooled APTIMA® HIV-1 RNA testing Ethridge Steven F, Sullivan T, Bennett B, Parker M, Hanson D, Hilliard J, Hart C, Patel P Diagnostic.
Please refer to the AimPlex assay user manual for details of the assay procedure.
Troubleshooting: ELISA & rapid may troubleshooting: ELISA may 2005.
Use of Dried Blood Spots (DBS) Specimens for Measuring HIV-1 Viral Load in Argentina M. Lorena Vázquez Inés Zapiola Ana Gun Silvia Gómez Alejandro Krolewiecki.
Storage, Retention, and Use of Residual Dried Blood Spots Storage, Retention, and Use of Residual Dried Blood Spots Harry Hannon, PhD and Brad Therrell,
Newborn Screening Quality Assurance Program Newborn Screening Quality Assurance Program Comparison of Less Sensitive HIV Incidence Tests for the Serological.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Use of avidity reagent. Panbio Buffered Avidity Reagent Mild protein-denaturing solution that may be useful in differentiating recent infections from.
A Simple and Inexpensive Particle Agglutination Assay for Identifying Recent HIV Infection Niel Constantine 1, Li Hong 2, Kristen Kreisel 1, Anne Sill.
Vironostika® HIV-1 Plus O Microelisa System
Packaging and Shipping Dried Blood Spot Samples (Cold Shipment)
Thoughts on Simplifying the Estimation of HIV Incidence John Hargrove, Alex Welte, Paul Mostert [and others]
Trends in HIV prevalence and HIV incidence in South Africa Thomas M. Rehle, MD, PhD Human Sciences Research Council (HSRC) Cape Town, South Africa AIDS.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Microbiology and Serology
Enzyme-Linked Immunosorbent Assay (ELISA) Mary Lea Killian USDA APHIS VS National Veterinary Services Laboratories Ames, Iowa.
OnSite Rubella IgG/IgM Rapid Test Novel Unique & Only Semi-Quantitative 4-Line Rapid Test.
Tests for Recent Infection and CDC’s Plans for the Detuned IND Bernard M. Branson, M.D. Centers for Disease Control and Prevention.
Joan Cid, Núria Nogués, Rosa Montero, Marta Hurtado, Albert Briega and Rafael Parra. Blood and Tissue Bank. Barcelona, Spain. Comparison of three microtube.
National Center for Environmental Health Centers for Disease Control and Prevention Suzanne Cordovado, Ph.D. Team Lead, Molecular Quality Improvement Program.
REAL-TIME RT-PCR BASED ASSAY ON BLOOD CLOT SPECIMENS FOR DIAGNOSIS OF HIV-1 INFECTION IN CHILDREN, MALAWI Hua Yang 1, Rita Helfand 2, Desiree Witte 3,
Cat # SL HEPG2 Store at 4 0 C GenJet  In Vitro DNA Transfection Reagent for HepG2 Cells (Ver. II) A Protocol for Transfecting HepG2 Cells.
HIV, HCV, and HBV NAT Controls Formulation, Stability and Performance Mark Manak BBI Diagnostics, Inc. A Division of SeraCare Life Sciences, Inc. SoGAT.
Cat # SL Store at 4 0 C LipoJet DNA In Vitro Transfection Reagent A Protocol for Transfections of Mammalian Cell 100 l 500 l 1000 l
Development of a detuned oral assay for recent HIV infection F. Priddy 1, P. Phelan 1, P. Tambe 1,2, C. del Rio 1 1 Emory University School of Medicine,
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES XVIII International AIDS Conference, July , Vienna Austria Recent Trends in estimated HIV-1.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
HIV INCIDENCE SURVEILLANCE (HIS) PROGRAM California Department of Public Health Office of AIDS Surveillance Section.
Enzyme-Linked Immunosorbent Assay. 2 Introduction ELISA Types Applications Principles.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Cat # SL Store at 4 0 C PolyJet In Vitro DNA Transfection Reagent A Protocol for Transfections of Mammalian Cell 100 l 500 l 1000 l
Cat # SL CHO Store at 4 0 C GenJet In Vitro DNA Transfection Reagent for CHO Cells (Ver. II) A Protocol for Transfections of CHO Cells 100.
QUALITY CONTROL IN MEDICAL MICROBIOLOGY Quality control is divided Internal quality control: performed locally inside External quality control:
Cat # SL Store at 4 0 C SL SuperFection™ DNA Transfection Reagent Small 0.5 ml Large 1.0 ml Gaither Drive Gaithersburg, MD FAX.
Further information: Performance of HIV Enzyme-Immunoassays on Dried Blood Spots for Quality Control of HIV Testing Dennis Olara 1,
Cat # SL Store at 4 0 C GenJet DNA In Vitro Transfection Reagent 100 l 500 l 1000 l Gaither Drive Gaithersburg, MD FAX
Module 8: Blood Collection and Handling Dried Blood Spot
2005 PNG National Nutrition Survey – Laboratory Procedures Overview.
Trends in HIV incidence in Ontario based on the detuned assay: Update to December 2002 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Robert.
Complement Fixation Test
Cat # SL Store at 4 0 C LipoD293 DNA In Vitro Transfection Reagent (Ver. II) 100  l 500  l 1000  l Gaither Drive Gaithersburg, MD
IMMUNOLOGY.
DISCONTINUATION OR NO DISCONTIUNATION: COMPARISON OF SINGLE UNIT HIV ANTIGEN TESTING VS. POOLED NAT TESTING Gerald Schochetman, Ph.D. Abbott Laboratories.
Cat # SL Store at 4 0 C GenJet™ siRNA Transfection Reagent Small 0.5 ml Large 1.0 ml Gaither Drive Gaithersburg, MD FAX
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
Methodologies and Regulations in Specimen Collection and Management Introduction.
ANTIMICROBIAL Used to select effective Not indicated if sensitivity pattern of a pathogen can be Not performed on commensals.
Absorbance: Enzyme Linked Immunosorbent Assays (ELISA)
Practical Hematology Lab
Absorbance Demo Tutorial
Discussion and Conclusions
Mammalian Cell l 500 l l Gaither Drive Gaithersburg, MD 20877
by James D. Cook, Carol H. Flowers, and Barry S. Skikne
ImmunoWELL Zika Virus Serology.
GenJet In Vitro DNA Transfection Reagent for Hela Cells (Ver
Preparation of QC and Training Panels
HIV-1 Rapid Test for Recent Infection
HIV-1 Rapid Test for Recent Infection
Presentation transcript:

Use of dried blood spots (DBS) or dried serum/plasma spots (DSS/DPS) to detect recent HIV-1 seroconversion by the BED-CEIA Bharat Parekh, PhD Centers for Disease Control and Prevention Atlanta, GA

Background/Objectives The BED-CEIA was developed and optimized to detect recent HIV-1 infections in serum specimens. Because this test will be performed mainly in central laboratories, blood from outlying areas need to be processed, stored frozen and shipped to the central laboratory Optimal storage and shipping can be very expensive and is not practical in many countries Extending use of the BED-CEIA to DBS, DSS or DPS can have major implications for incidence surveillance worldwide.

Initial optimization Done using matched serum and serum spot controls IgG eluted from 6mm punch using PBS/Triton or BSA/PBS/Triton (specimen diluent) Application of the protocol to a small batch of paired specimens Preparation of DBS, DSS/DPS and wider applications Preparation of controls as serum spots NC CAL LPC HPC

Use of DBS and serum spots: Optimized procedure Preparation : 50  l of serum or 100  l blood on SS# 903 Dry overnight in the hood, store in sealed bag with desiccant Using 6mm puncher, make one punch into a 96-well blank plate Add 200  l specimen diluent, mix and incubate overnight at 4-8 C for IgG elution Next day, add 50  l of specimen diluent to the BED assay plate. Transfer 50  l of eluant to the BED plate, mix and perform the assay as described starting with specimen incubation Use serum spot controls and CAL for calculating OD-n

Schematic of the procedure μl of mix, let IgG elute Diluent at 4 C/overnight mm punch DSS or DBS Blank 96-well plate Add 50 μ l of diluent to the BED assay plate and transfer 50 μ l of eluants, Follow the steps as in regular assay starting with specimen incubation

Specimens A total of 205 matched DBS and serum specimens were available DSS were prepared as described Serum, DBS and DSS were tested in parallel by the BED assay Serum results compared to DBS and DSS Stability study of DSS

Correlation between serum and serum spots

Correlation between serum and DBS

Correlation between DSS and DBS

Overall Concordance RECENTLTTOTAL SERUM DBS DSS Agreement between diff specimens types Recent LTTotal % Agree SERUM+DBS SERUM+DSS DBS + DSS ALL THREE

Stability of DSS on filter paper Controls and 5 member panel were spotted on SS # 903 as DSS Stability at –20 C, 4 C, 25 C and 37 C Periodic testing and comparison of raw OD and OD-n

Stability of DSS at 37 C Raw OD

Stability of DSS at 37 C OD-n

Serum spots are stable for at least 99 days at 37 C

Conclusions We have developed an optimized protocol for use of the DBS or DSS with the BED assay; results are similar to those obtained with matched serum specimens Controls and calibrator are prepared as DSS on # 903 filter paper to match the sample matrix Current data indicate that DSS are stable for >3 37 C, >5 25 C, 4 C and -20 C. Additional stability studies are ongoing. These findings may have major implications for extending the use of the BED assay in many settings for HIV-1 incidence estimates.

Acknowledgement Susan Phillips Trudy Dobbs Debbie Kuehl